{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T14:47:47Z","timestamp":1772635667398,"version":"3.50.1"},"reference-count":22,"publisher":"Manuscript Technomedia LLP","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Young Pharmacists"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.4103\/0975-1483.66807","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T10:56:22Z","timestamp":1280919382000},"page":"326-331","source":"Crossref","is-referenced-by-count":45,"title":["Drug Interaction and Pharmacist"],"prefix":"10.5530","volume":"2","author":[{"given":"J.A.","family":"Ansari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3478","reference":[{"key":"10.4103\/0975-1483.66807_bb0005","series-title":"Preclinical Development Handbook: ADME and Biopharmaceutical Properties","first-page":"879","article-title":"Mechanisms and consequences of drug-drug interactions","author":"Farkas","year":"2008"},{"key":"10.4103\/0975-1483.66807_bb0010","first-page":"1745","article-title":"Clinically significant drug interactions","volume":"61","author":"Ament","year":"2000","journal-title":"Am Fam Physician"},{"key":"10.4103\/0975-1483.66807_bb0015","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2710.2009.01023.x","article-title":"Multiple drug interactions-induced serotonin syndrome: A case report","volume":"34","author":"Montan\u00e9","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"10.4103\/0975-1483.66807_bb0020","unstructured":"MedWatch-What Is A Serious Adverse Event? Available from: http: \/\/ www. fda.gov\/medwatch\/report\/DESK\/ advevnt.htm [last retrieved on 2007 Sep 18]."},{"key":"10.4103\/0975-1483.66807_bb0025","unstructured":"Clinical Drug Use. Available from: http:\/\/www.clinicaldruguse.com\/ [last retrieved on 2007 Sep 18]."},{"key":"10.4103\/0975-1483.66807_bb0030","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1001\/jama.286.18.2270","article-title":"Potential role of pharmacogenomics in reducing adverse drug reactions: A systematic review","volume":"286","author":"Phillips","year":"2001","journal-title":"JAMA"},{"key":"10.4103\/0975-1483.66807_bb0035","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJMe020173","article-title":"Pharmacogenetics in the laboratory and the clinic","volume":"348","author":"Goldstein","year":"2003","journal-title":"N Engl J Med"},{"key":"10.4103\/0975-1483.66807_bb0040","unstructured":"Drug-Interactions.com. Available from: http:\/\/www.medicine.iupui.edu\/ flockhart\/ [last retrieved on 2007 Sep 18]."},{"key":"10.4103\/0975-1483.66807_bb0045","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMra020021","article-title":"Inheritance and drug response","volume":"348","author":"Weinshilboum","year":"2003","journal-title":"N Engl J Med"},{"key":"10.4103\/0975-1483.66807_bb0050","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1056\/NEJMra020526","article-title":"Pharmacogenomics\u2013drug disposition, drug targets, and side effects","volume":"348","author":"Evans","year":"2003","journal-title":"N Engl J Med"},{"key":"10.4103\/0975-1483.66807_bb0055","doi-asserted-by":"crossref","unstructured":"Sands CD, Chan ES, Welty TE. Revisiting the significance of warfarin protein-binding displacement interactions. Ann Pharmacother 2002;36:1642-4. Available from: http:\/ \/www.theannals.com\/cgi\/reprint\/36\/10\/1642 [last cited on 2010 Jan 20].","DOI":"10.1345\/aph.1A208"},{"key":"10.4103\/0975-1483.66807_bb0060","series-title":"Program and abstracts of The American Society of Health-System Pharmacists Midyear Clinical Meeting 2000","article-title":"Applying the knowledge of pharmacogenetics and pharmacogenomics in the management of drug interactions","author":"Chan","year":"2000"},{"key":"10.4103\/0975-1483.66807_bb0065","first-page":"1519","article-title":"A study on assessment, monitoring, documentation and reporting of adverse drug reactions at a multi-specialty ertiary care teaching hospital in South India","volume":"4","author":"Palanisamy","year":"2009","journal-title":"Int J PharmTech Res"},{"key":"10.4103\/0975-1483.66807_bb0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1086-5802(16)31230-X","article-title":"Performance of community pharmacy drug interaction software","volume":"41","author":"Hazlet","year":"2001","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"10.4103\/0975-1483.66807_bb0075","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1532-5415.1996.tb01865.x","article-title":"Drug-drug interactions related to hospital admissions in older adults: A prospective study of 1000 patients","volume":"44","author":"Doucet","year":"1996","journal-title":"J Am Geriatr Soc"},{"key":"10.4103\/0975-1483.66807_bb0080","series-title":"US Food and Drug Administration","article-title":"Label changes for Simvastatin (Zocor)","author":"Orloff","year":"2002"},{"key":"10.4103\/0975-1483.66807_bb0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1331\/108658002763316879","article-title":"The role of pharmacy computer systems in preventing medication errors","volume":"42","author":"Chrischilles","year":"2002","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"10.4103\/0975-1483.66807_bb0090","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-200241050-00003","article-title":"Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors","volume":"41","author":"Williams","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.4103\/0975-1483.66807_bb0095","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0735-1097(02)02030-2","article-title":"ACC\/AHA\/NHLBI clinical advisory on the use and safety of statins","volume":"40","author":"Pasternak","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.4103\/0975-1483.66807_bb0100","first-page":"53","volume":"10","author":"Ogbru","year":"1996","journal-title":"Drug-food interactions. Clin Trends Pharm Pract"},{"key":"10.4103\/0975-1483.66807_bb0105","first-page":"59","article-title":"Drug interactions with grapefruit juice","volume":"1","author":"Ogbru","year":"1997","journal-title":"Drug Links"},{"key":"10.4103\/0975-1483.66807_bb0110","unstructured":"Bihari M. Drug interactions: Reducing your risk. American academy of family physician. Available from: http:\/\/www.About.com [last cited on 2000 Mar 15]."}],"container-title":["Journal of Young Pharmacists"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:55:41Z","timestamp":1771577741000},"score":1,"resource":{"primary":{"URL":"https:\/\/jyoungpharm.org\/article\/2\/3\/326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0975148310230236"],"URL":"https:\/\/doi.org\/10.4103\/0975-1483.66807","relation":{},"ISSN":["0975-1483"],"issn-type":[{"value":"0975-1483","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}